CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cambridge BioMarketing, an Ashfield company, part of UDG Healthcare plc and the world’s leading rare disease agency, today announced ‘Rare in Common,’ a new podcast aimed at elevating the voice of the rare disease community.
Launched in conjunction with Rare Disease Day, the podcast continues the legacy of Cambridge BioMarketing’s 2016 Rare in Common film, which follows the experience of rare families and honors people facing the challenges of rare diseases. Just as the film focuses on the lives of inspiring people in the rare community, the podcast will carry on the mission of highlighting the trials of–and commonalities between–the journeys of patients with rare diseases. Listeners will have the opportunity to hear updates from many of the individuals originally featured in the film, learn about the lives of new patients and families, and benefit from insights shared by a broader community of rare disease stakeholders— advocates, physicians, researchers, industry executives, and other key opinion leaders.
“Our agency is driven forward by our passion for helping rare patients, and each year Rare Disease Day is a special opportunity to leverage our cross-functional expertise to introduce yet another creative way to boost awareness for the community,” said Maureen Franco, CEO, Cambridge BioMarketing. “The concept behind ‘Rare in Common’ is the commonality of people with rare disease: no matter what the disease, rare patients and their families share similar struggles, perseverance, and journeys. We’ve borne witness to countless patient quests, and it is an honor for us to provide a platform to help amplify their voices.”
Today marks Cambridge BioMarketing’s sixth anniversary of honoring Rare Disease Day. Held each year at the end of February, the goal of Rare Disease Day is to raise awareness for the estimated 350 million people worldwide who suffer from rare diseases. The podcast comes on the heels of the agency’s successful 2017 Rare Disease Day social media campaign, #SupportTheSearch, which raised awareness and funds for rare disease research.
Updated on a monthly basis, the podcast’s first three episodes, available now, are hosted by patient advocate Andra Stratton, and feature updates from three of the “rare moms” included in the film: Patty Weltin, Janis Creedon, and Jenn McNary.
“Every rare disease is different but they all have rare in common,” added Franco. “We want this podcast to echo what Rare in Common accomplished when we premiered it two years ago, showcasing the common traits of rare to create a unified and louder voice, strengthen the rare disease community, and give people a source of hope.”
To listen to the podcast, please visit: Rareincommon.com.
About Cambridge BioMarketing
Founded in 2001, Cambridge
BioMarketing is a US-based communications agency with over 100 employees
specializing in rare orphan diseases. Headquartered in Cambridge, MA
with offices in Oakland, CA, Cambridge BioMarketing is an industry
leader in orphan drug launches, advising pharmaceutical companies with
an integrated focus on both traditional healthcare professional programs
and direct-to-patient work. In partnering with predominantly
pharmaceutical and biotech customers, the agency’s goal is to bring
physicians, specialists, and patient communities together on behalf of
clients to transform human health in the face of
devastating, underappreciated disease states. Cambridge BioMarketing’s
primary service offerings include launch readiness support, digital
strategy, market analytics, integrated marketing, patient identification
and acquisition, medical affairs support, line extensions, and patient
retention and adherence programs.
For more information, please go to: http://cambridgebmg.com/
About Ashfield:
Ashfield Commercial & Medical Services, part
of UDG Healthcare plc, is a global leader in providing outsourced
healthcare services to pharmaceutical, device, and biotech companies.
The company has more than 7000 employees, operates in 23 countries
across Europe, North America, South America, and Asia and works with
more than 250 companies, including all of the world’s top-25
pharmaceutical companies. Its mission is to partner with its clients,
improving lives by helping healthcare professionals and patients get the
medicines, knowledge, and support they need.
Ashfield provides contract sales teams, customer service reps, medical science liaison officers, remote detailing, nurse educators, medical information, healthcare communications, market access, market research, training, event management, digital, creative, and pharmacovigilance services.
For more information, go to www.ashfieldhealthcare.com.
